ORBi: Arijs I. - The impact of infliximab therapy on intestinal mucosal expression of matrix metalloproteinase and ADAM genes in patients with inflammatory bowel disease.

Reference : The impact of infliximab therapy on intestinal mucosal expression of matrix metalloprote...


	Document type :	Scientific journals : Other
	Discipline(s) :	Human health sciences : Gastroenterology & hepatology
	To cite this reference:	http://hdl.handle.net/2268/56483

Title :	The impact of infliximab therapy on intestinal mucosal expression of matrix metalloproteinase and ADAM genes in patients with inflammatory bowel disease.
Language :	English
Author, co-author :	Arijs, I. [ > > ]
	Lemaire, K. [ > > ]
	Quintens, R. [ > > ]
	Van Lommel, L. [ > > ]
	Perrier, C. [ > > ]
	Van Steen, Kristel [Université de Liège - ULg > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Bioinformatique >]
	De Hertogh, G. [ > > ]
	Van Assche, G. [ > > ]
	Vermeire, S. [ > > ]
	Geboes, K. [ > > ]
	Schuit, F. [ > > ]
	Rutgeerts, P. [ > > ]
Publication date :	2009
Journal title :	Gut
Publisher :	BMJ Group
Audience :	International
ISSN :	0017-5749
e-ISSN :	1458-3288
City :	London
Country :	United Kingdom
Permalink :	http://hdl.handle.net/2268/56483

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	Arijs2009_MMPs and ADAMs_gut to appear.pdf		Author preprint	16.03 kB	Request copy

All documents in ORBi are protected by a user license.